US Targets Central Bank Of Russia In Latest Sanctions
In order to put further pressure on Russian President Vladamir Putin, the United States on Monday targeted Russia's central bank with new sanctions.
Meta Says It Took Down Malicious Network Spreading Claims of Ukraine Being A Failed State And Western Betrayal
Facebook parent Meta Platforms Inc. (NASDAQ: FB) said it is rolling out more privacy and security measures to help people in Ukraine following the country’s invasion by Russia.
Here’s Why Russia Looks To Partially Limit Facebook Access
Russia’s communications regulator Roskomnadzor, the Russian federal executive agency responsible for monitoring, controlling, and censoring Russian mass media,…
Lithium Americas Receives Final Key State Permits For Thacker Pass; Provides Update On Federal Permitting Timeline
Lithium Americas Corp. (TSX:LAC) (NYSE:LAC) ("Lithium Americas" or the "Company") is pleased to announce the Nevada Division of Environmental Protection (“NDEP”) has issued the final key
S&P Global And IHS Markit Announce Final Regulatory Approval For Merger And Expected Close On February 28, 2022
S&P Global (NYSE:SPGI) and IHS Markit (NYSE:INFO) today announced that the UK's Competition and Markets Authority and the European Commission have granted the final regulatory approvals necessary for the
Nabis, California’s Largest Cannabis Wholesaler To Apply For License In New York
Nabis, a fully-licensed cannabis wholesale platform with the largest portfolio of cannabis brands in the world, supplying 100% of California’s dispensaries and delivery services, plans to apply for a distribution license in New York.
Just When You Thought It Was Safe…MedMen And Ascend Wellness Are Back On The Mat Again In New York
Just in case you thought it was safe to stop thinking about the conflict between MedMen (CSE: MMEN) (OTCQX: MMNFF) and Ascend Wellness Holdings (OTCQX: AAWH), a new twist pulls you right back in.
CbdMD Requests FDA Remove Drug Exclusion For CBD And Examine Its Safety Submission
Natural Products Association filed a Citizen's Petition on cbdMD's (NYSE: YCBD) behalf with the Food and Drug Administration (FDA) requesting it remove the drug exclusion for CBD and review the company's extensive dossier of identity, safety and quality data.</
Psyched: Psilocybin Therapy Effective After One Year, Cybin & Deepak Chopra, Enveric Psilocybin Cancer Study
Psilocybin received yet another confirmation of its beneficial effects in the treatment of major depressive disorder, this time, in the long term. A new Johns Hopkins review study found that the positive effects of just two sessions of psilocybin-assisted psychotherapy can last for over one year in most patients with depression.